Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (6): 383-384.
YANG Jiyang1,2, CUI Xiangli2, Wu Xinan1,*
Received:2018-12-30
Revised:2019-07-12
Online:2019-06-20
Published:2019-07-12
CLC Number:
YANG Jiyang, CUI Xiangli, Wu Xinan. Two Cases of Acute Pulmonary Embolism Induced by Antipsychotic Drugs[J]. Chinese Journal of Pharmacovigilance, 2019, 16(6): 383-384.
| [1] 武忠弼. 病理学[M].4版.北京:人民卫生出版社.1999:52-54. [2] Jesus C, Jesus I, Agius M.A review of the evidence for the use of metformin in the treatment of metabolic syndrome caused by antipsychotics[J]. Psychiatr Danub, 2015, 27(Suppl 1): 489-491. [3] Walker A M, Lanza L L, Arellano F, et al.Mortality in current and former users of clozapine[J]. Epidemiology, 1997, 8(6):671-677. [4] Borras L, Eytan A, De T P, et al.Pulmonary Thromboembolism Associated with Olanzapine and Risperidone[J]. Journal of Emergency Medicine, 2008, 35(2):159-161. [5] Axelsson S, H gg S, Eriksson A C, et al.In vitro, effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation[J]. Clin Exp Pharmacol Physiol, 2007, 34(8):775-780. [6] Wallaschofski H, Eigenthaler M, Kiefer M, et al.Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous throm-boembolism: pilot study[J]. Journal of Clinical Psychopharmacology, 2003, 23(5):479-483. [7] Canoso R T, de Oliveira R M, Nixon R A. Neuroleptic-associated autoantibodies. A prevalence study[J]. Biol Psychiatry, 1990, 27(8):863-870. [8] Allenet B, Schmidlin S, Genty C, et al.Antipsychotic drugs and risk of pulmonary embolism[J]. Pharmacoepidemiology & Drug Safety, 2012, 21(1):42-48. [9] Shulman M, Jennifer N I, Manu P.Thrombotic complications of treatment with antipsychotic drugs[J]. Minerva Medica, 2013, 104(2):175. [10] Zink M, Knopf U, Argiriou S, et al.A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone[J]. J Clin Psychiatry, 2006, 67(5):835. [11] DWH Tam .Sudden Death from Pulmonary Hypertension in a Depressed Patient:a Case Report[J]. Hong Kong J Psychiatry, 2009, 19(4):155-158. [12] 刘彦会,杨苏乔,王颖,等. 米氮平片和盐酸氯米帕明片合用致急性肺栓塞1例[J]. 中国药物警戒, 2018,15(6):375-376. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
